Thursday | Business Wire
Public relations, press release distribution, investor relations, SEC filing
All times in Eastern Time. NEW ORLEANS-- --Millennium: The Takeda Oncology Company today reported updated results based on a planned median three-year follow up of patients from the large, international Phase III... BOTHELL, Washington-- --SonoSite Inc., societa leader a livello mondiale specializzata in apparecchi ecografici portatili per l'uso ...
The Addition of VELCADE (Bortezomib) for Injection to Novel...
Dec 8, 2009 - Millennium: The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin's lymphoma .
VELCADE (Bortezomib) for Injection Based Combinations Deliver...
Dec 7, 2009 - Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma .
Velcade (Bortezomib) for Injection to be Featured in Plenary Session...
These abstracts include an oral presentation of data on successful VELCADE utilization in both induction and maintenance in the front-line setting during the distinguished plenary session being held on Sunday, December 6. The ASH Program Committee selects for the plenary session the most ground-breaking abstracts of the conference.
Who's coming? Who's going? Who's changing places?
CleanTech Stan Haftka has been named director of business development, Europe, for Telles, the joint venture between Cambridge-based Metabolix Inc.
Osaka-based Takeda Pharmaceutical Co. may consider acquisitions in South America and is interested in expanding in generic drugs, President Yasuchika Hasegawa said yesterday.
Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor
Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Companya s second-generation proteasome inhibitor.
Scholarship winners recognized at Conestoga 2009-11-9
The winners of the Millennium Excellence National In-course Awards for Conestoga College were recognized at the latest board of governors meeting on Oct.
Cambridge college buys top London music venue
But the 500-year-old college, one of the wealthiest academic institutions, has bought The O2, London 's top music venue, where Led Zeppelin staged their famous comeback and Michael Jackson planned to do so, too.
IF THERE'S ONE THING that's essential for getting work done, it might be coffee.
Alnara taps biotech vet Brettman to navigate drug-approval process
Alnara Pharmaceuticals , a privately held Cambridge, Mass.-based biotechnology company with a late stage cystic fibrosis drug target, has appointed its first chief medical director.
Playing their cross-cultural cards right
Keiko Sakurai held up a business card for her audience of 20 biotechnology managers whose company, Millennium Pharmaceuticals Inc.
Takeda First-Half Profit Jumps, Beats Analysts' Estimates on Lower Costs
Takeda Pharmaceutical Co. , maker of the worlda s best-selling diabetes drug Actos, posted first-half profit that more than doubled on lower expenses, while cutting its revenue outlook because of weaker sales and the stronger yen.
Millennium Initiates Phase II Trial For Diffuse Large B-Cell Lymphoma
Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Cancer / Oncology Clinical Trials / Drug Trials Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone with or without VELCADE for Injection for patients with a ...
Aileron Therapeutics appoints Kafka as CFO
Protein-focused biotech company Aileron Therapeutics Inc. has named Steven Kafka as its chief financial officer and vice president of finance and operations.
Improve your odds of a big lottery win
WOULD you like to improve your chances of winning the National Lottery? Well at expert mathematician will be telling students this week how they can do just that.
Cambridge's Trinity College has acquired Meridian Delta Dome, the company that holds the 999 year lease on London's Millennium Dome, for 24 million pounds.
Trinity College Cambridge buys into the O2 Arena in A 24m deal
The wealthiest Cambridge college has bought into the O2 Arena in London in a 24 million deal.
99 Cents Only Stores shares down 3%
THE peace prize? after 9 months in office? Who was the competition? Hugo Chavez, Idi Amin, and Osama Bin Laden? A a ' Oscar77 /conga/kiosk/community.html 33906 1252655100000 1252656000000 Asia Macau casino tycoon: Boom over Lawrence Ho says the credit crisis has ended Macau's casino-building frenzy.
FDA Grants Priority Review Status To Supplement Containing Long-Term...
FDA Grants Priority Review Status To Supplement Containing Long-Term Survival Data For VELCADE For Injection Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Cancer / Oncology Blood / Hematology Millennium: The Takeda Oncology Company announced that the U.S. Food and Drug Administration has granted priority review to the Company's ...
Also on Topix